Anti-phospholipid syndrome nephropathy;La néphropathie liée aux anticorps anti-phospholipides

Annales de Medecine Interne

Volumn 154, Issue 1, 2003, Pages 51-58

  Nochy, Dominique ^a   Daugas, Eric ^b   Hill, Gary ^a   Piette, Jean Charles ^c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL TENON   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anti cardiolipin; Lupus anticoagulant; Nephropathy; Primary anti phospholipid syndrome; Renal biopsy; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CONFERENCE PAPER; FETUS WASTAGE; FIBROSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; RENAL CIRCULATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0344406284     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (66)

1. HARMS EN, CHAN JK, ASHERSON RA, ABER VR, GHARAVI AE, HUGHES GR: Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med, 1986; 146: 2153-6.
2. ASHERSON RA: A "primary" antiphospholipid syndrome? J Rheumatol, 1988; 15: 1742-6.
3. FONT J, CERVERA R: Sindrome antifosfolipido primario: una nueva entidad? Med Clin (Barc), 1988; 91: 736-8.
4. ALARCON-SEGOVIA D, SANCHEZ-GUERRERO J: Primary antiphospholipid syndrome. J Rheumatol, 1989; 16: 482-8.
5. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, et al.: The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore), 1989; 68: 366-74.
6. WILSON WA, GHARAVI AE, KOIKE T, et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999; 42: 1309-1.
7. KANT KS, POLLAK VE, WEISS MA, GLUECK HI, MILLER AN, HESS EV: Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore), 1981; 60: 71-86.
8. GLUECK HI, KANT KS, WEISS MA, POLLAK VE, MILLER MA, COOTS M: Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med, 1985; 145: 1389-95.
9. ALARCON-SEGOVIA D, DELEZE M, ORIA CV, et al.: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore), 1989; 68: 353-65.
10. FRAMPTON G, HICKS J, CAMERON JS: Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int, 1991; 39: 1225-31.
11. PIETTE JC, CACOUB P, WECHSLER B: Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum, 1994; 23: 357-66.
12. BECQUEMONT L, THERVET E, RONDEAU E, LACAVE R, MOUGENOT B, SRAER JD: Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy. Am J Nephrol, 1990; 10: 254-8.
13. AMIGO MC, GARCIA-TORRES R, ROBLES M, BOCHICCHIO T, REYES PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol, 1992; 19: 1181-5.
14. LACUEVA J, ENRIQUEZ R, CABEZUELO JB, ARENAS MD, TERUEL A, GONZALEZ C: Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome. Nephron, 1993; 64: 479-80.
15. SOKUNBI DO, MILLER F, WADHWA NK, NORD EP: Reversible renal failure in the primary antiphospholipid syndrome: a report of two cases. J Am Soc Nephrol, 1993; 4: 28-35.
16. DOMRONGKITCHAIPORN S, CAMERON EC, JETHA N, KASSEN BO, SUTTON RA: Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron, 1994; 68: 128-32.
17. HAMIDOU MA, MOREAU A, JEGO P, et al.: Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome. Am J Kidney Dis, 1995; 25: 486-8.
18. KLEINKNECHT D, BOBRIE G, MEYER O, NOEL LH, CALLARD P, RAMDANE M: Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant, 1989; 4: 854-8.
19. D'AGATI V, KUNIS C, WILLIAMS G, APPEL GB: Anticardiolipin antibody and renal disease: a report three cases. J Am Soc Nephrol, 1990; 1: 777-84.
20. LEAKER B, MCGREGOR A, GRIFFITHS M, SNAITH M, NEILD GH, ISENBERG D: Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol, 1991; 30: 422-5.
21. HUGHSON MD, NADASDY T, MCCARTY GA, SHOLER C, MIN KW, SILVA F: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis, 1992; 20: 150-8.
22. SCOLARI F, SAVOLDI S, COSTANTINO E, et al.: Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis. Nephrol Dial Transplant, 1993; 8: 1274-6.
23. HUGHSON MD, MCCARTY GA, BRUMBACK RA: Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol, 1995; 26: 716-24.
24. ISENBERG DA, GRIFFITHS M, NEILD GH: Woman with livedo reticularis, renal failure, and benign urinary sediment. Nephrol Dial Transplant, 1995; 10: 295-7.
25. SIRVENT AE, ENRIQUEZ R, ANTOLIN A, CABEZUELO JB, GONZALEZ C, ARENAS MD: Malignant hypertension and antiphospholipid syndrome. Nephron, 1996; 73: 368-9.
26. NOCHY D, DAUGAS E, DROZ D, et al.: The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol, 1999; 10: 507-18.
27. PETRAS T, RUDOLPH B, FILLER G, et al.: An adolescent with acute renal failure, thrombocytopenia and femoral vein thrombosis. Nephrol Dial Transplant, 1998; 13: 480-3.
28. KINCAID-SMITH P, FAIRLEY KF, KLOSS M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med, 1988; 68: 795-815.
29. PEREZ RE, MCCLENDON JR, LIE JT: Primary antiphospholipid syndrome with multiorgan arterial and venous thromboses. J Rheumatol, 1992; 19: 1289-92.
30. PIETTE JC, KLEINKNECHT D, BACH JF: Renal manifestation in the antiphospholipid syndrome. In: ASHERSON RA, CERVERA R, PIETTE JC, SCHOENFELD Y, eds. The antiphospholipid syndrome. Boca Raton: CRC Press, 1996: 169-81.
31. ASHERSON RA, CERVERA R, PIETTE JC, et al.: Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore), 1998; 77: 195-207.
32. NOCHY D, BARRES D, CAMILLERI JP, BARIETY J, CORVOL P, MENARD J: Abnormalities of renin-containing cells in human glomerular and vascular renal diseases. Kidney Int, 1983; 23: 375-9.
33. RAMDANE M, GRYMAN R, BACQUES O, CALLARD P, KLEIN-KNECHT D: [Renal cortex ischemia, right atrial thrombosis and coronary occlusion in anti-phospholipid antibody syndrome]. Nephrologie, 1989; 10: 189-93.
34. QUEREDA C, PASCUAL J, PARDO A, MAMPASO F, GONZALO A, ORTUNO J: Thrombotic microangiopathic nephropathy in scleroderma and lupus anticoagulant. Nephron, 1991; 59: 651-3.
35. LOVE PE, SANTORO SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med, 1990; 112: 682-98.
36. BANFi G, BERTANI T, BOERI V, et al.: Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis, 1991; 18: 240-8.
37. FARRUGIA E, TORRES VE, GASTINEAU D, MICHET CJ, HOLLEY KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis, 1992; 20: 463-71.
38. BRIDOUX F, VRTOVSNIK F, NOEL C, et al.: Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol Dial Transplant, 1998; 13: 298-304.
39. CACOUB P, WECHSLER B, PIETTE JC, et al.: Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin Exp Rheumatol, 1993; 11: 479-85.
40. BHATHENA DB, SOBEL BJ, MIGDAL SD: Noninflammatory renal microangiopathy of systemic lupus erythematosus ("lupus vasculitis"). Am J Nephrol 1981; 1: 144-59.
41. GREISMAN SG, THAYAPARAN RS, GODWIN TA, LOCKSHIN MD: Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med, 1991; 151: 389-92.
42. SCHWATZ M: Lupus vasculitis. In: SESSA A, MERONI M, BATTINI G, eds. Systemic lupus erythematosus. Basel: Karger, 1992: 35-45.
43. DESCOMBES E, DROZ D, DROUET L, GRUNFELD JP, LESAVRE P: Renal vascular lesions in lupus nephritis. Medicine (Baltimore), 1997; 76: 355-68.
44. DAUGAS E, NOCHY D, HUONG DU LT, et al.: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol, 2002; 13: 42-52.
45. CERVERA R, KHAMASHTA MA, FONT J, et al.: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore), 1993; 72: 113-24.
46. D'ANGELO A, SAFA O, CRIPPA L, GARLANDO A, SABBADINI MG, VIGANO-D'ANGELO S: Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and antiprothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome. Thromb Haemost, 1997; 78: 967-8.
47. ASHERSON RA, BAGULEY E, PAL C, HUGHES GR: Antiphospholipid syndrome: five year follow up. Ann Rheum Dis, 1991; 50: 805-10.
48. PIETTE JC, WECHSLER B, FRANCES C, PAPO T, GODEAU P: Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol, 1993; 20: 1802-4.
49. LEVINE JS, BRANCH DW, RAUCH J: The antiphospholipid syndrome. N Engl J Med, 2002; 346: 752-763.
50. JOUQUAN J, PENNEC Y, MOTTIER D, et al.: Accelerated hypertension associated with lupus anticoagulant and falsepositive VDRL in systemic lupus erythematosus. Arthritis Rheum, 1986; 29: 147.
51. PRIETO LN, SUKI WN: Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am J Kidney Dis, 1994; 23: 587-90.
52. BRUNET P, AILLAUD MF, SAN MARCO M, et al.: Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int, 1995; 48: 794-800.
53. RADHAKRISHNAN J, WILLIAMS GS, APPEL GB, COHEN DJ: Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis, 1994; 23: 286-9.
54. WAGENKNECHT DR, BECKER DG, LEFOR WM, MC INTYRE JA: Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation, 1999; 68: 241-6.
55. STONE JH, AMEND WJ, CRISWELL LA: Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis, 1999; 34: 1040-7.
56. GALLI M, COMFURIUS P, BARBUI T, ZWAAL RFA, BEVER EM: Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
57. ROUBEY RAS: Mechanisms of autoantibody-mediated thrombosis. Lupus, 1998; 7 (suppl 2): S114-9.
58. SAMMARITANO L, NG S, SOBEL R, et al.: Anticardiolipin IgG subclasses. Arthritis Rheum, 1997; 40: 1998-2006.
59. ATSUMI T, KHAMASHTA AM, HAWORTH RS, et al.: Arterial disease and thrombosis in the antiphospholipid syndrome. A pathogenic role for Endothelin I. Arthritis Rheum, 1998; 41: 800-7.
60. DUSSAULE J, THARAUX PL, BOFFA J, FAKHOURI F, ARDAILLOU R, CHATZIANTONIOU C: Mechanisms mediating the renal profibrotic actions of vasoactive peptides in transgenic mice. J Am Soc Nephrol, 2000; 11: S124-8.
61. BOFFA J, THARAUX PL, PLACIER S, ARDAILLOU R, DUSSAULE J, CHATZIANTONIOU C: Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis. Circulation, 1999; 100: 1901-8.
62. FAKHOURI F, PLACIER S, ARDAILLOU R, DUSSAULE J, CHATZIANTONIOU C: Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. J Am Soc Nephrol, 2001; 12: 2701-10.
63. LEVIN ER: Endothelins. N Engl J Med, 1995; 333: 356-63.
64. FOGO AB: Fibrose rdnale et système rénine-angiotensine. Actual Nephrol, 2001; 31: 73-88.
65. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GR: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med, 1995; 332: 993-7.
66. ASHERSON RA, CERVERA R, PIETTE JC, et al. Catastrophic antiphospholipid syndrome. Clues to pathogenesis from a series of 80 patients. Medicine (Baltimore), 2001; 80: 355-77.